Locking horns with activist investor Starboard Value, Pfizer CEO Albert Bourla’s position seems increasingly secure. Credit: Ryan Muir/ Getty Images Amidst dwindling share prices and widespread criticism, Pfizer CEO Albert Bourla appears to have withstood an attempted ousting by activist […]
How Pfizer management outplayed activist investor Starboard Read More »
The study published in Nature shows the drastic economic cost of obesity through medical expenses and lost productivity. Credit: zimmytws/Getty Images A new study published in Nature Nutrition & Diabetes estimates the economic burden associated with obesity on major US
New study finds obesity costs US industry $347bn a year Read More »
The study published in Nature shows the drastic economic cost of obesity through medical expenses and lost productivity. Credit: zimmytws/Getty Images A new study published in Nature estimates the economic burden associated with obesity on major US industries to have
Nature study finds obesity costs US industry $347bn a year Read More »
Life sciences analysts discussed the sector’s future following US, EU, and UK elections at the Jefferies London Healthcare Conference 2024. Credit: Frankie Fattorini/GlobalData The outcomes of this year’s US, EU, and UK elections and their downstream effects will lead to
Worldwide 2024 elections pose pivotal shifts in life sciences and healthcare Read More »
Experts disagree on whether DPIs or low emissions pMDIs are the way forward for effective, environmentally friendly inhalers. Credit: Pixel-Shot/Shutterstock In a bid to improve the pharma sector’s drive to cut down greenhouse emissions, several companies are advancing dry powder
Are dry powder inhalers the key to sustainable respiratory care? Read More »
Minister for Science Lord Vallance said Labour seek closer ties with commercial clinical industry to ignite innovation. Credit: Frankie Fattorini/GlobalData Lord Patrick Vallance has emphasised plans for a close collaboration between the government and private sector, in line with the
Minister for Science champions partnerships with private clinical sector in UK Read More »
The Danish companies aim to jointly develop a GLP-1RA administered once a month. Credit: Kittyfly / Shutterstock Novo Nordisk and Ascendis Pharma have agreed to collaborate in developing metabolic and cardiovascular therapies, among them a once-monthly glucagon-like peptide receptor agonist
Novo Nordisk signs $285m deal with Ascendis to create once-monthly GLP-1RA Read More »
Pfizer CEO Dr Albert Bourla presided over an exceptional Q3 amid financial decline and pressure from investor Starboard Value. Credit: Ververidis Vasilis / Shutterstock. Pfizer has reported strong revenues in its latest earnings report, noting increased revenues over Q3 2023
Pfizer boasts over 30% increase in Q3 revenues against previous year Read More »
: SP-624 may treat depression in women by modulating the distinct female genetic profile. Credit: Prathankarnpap/Shutterstock Arrivo BioVentures’ SIRT6 activator SP-624 has been found to significantly reduce symptoms of major depressive disorder (MDD), but only in women. Steve Butts, Arrivo
Arrivo targets major depressive disorder in females after early efficacy data Read More »
J&J’s Darzalex-VRd can now be given to newly diagnosed MM patients eligible for ASCT. Credit: Michael Vi/Shutterstock The European label for Johnson and Johnson Innovation Medicine’s (J&J) Darzalex (daratumumab) has been expanded to include patients with newly diagnosed multiple myeloma
J&J’s Darzalex combination gains expanded label for multiple myeloma in Europe Read More »
